CANNABINOIDS

Course overview

CANNABINOIDS ARE BIOLOGICALLY ACTIVE COMPOUNDS USED IN THE MANAGEMENT AND TREATMENT OF APPETITE/WEIGHT LOSS FROM HIV/AIDS AND CHEMOTHERAPY IN ADDITION TO EPILEPSY. IT IS IN THE ANTI-EMETICS AND ANTI-EPILEPTIC CLASS OF MEDICATIONS PER THE FOOD AND DRUG ADMINISTRATION (FDA). THIS ACTIVITY OUTLINES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR CANNABINOIDS AS A VALUABLE AGENT IN THE MANAGEMENT OF THE BEFORE MENTIONED DISEASES. MOREOVER, THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH APPETITE OR WEIGHT LOSS OR EPILEPSY.